Bank Of America Corp Paratek Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.52 - $2.8 $37,145 - $68,426	-24,438 Reduced 41.48%	34,480 $76,000
Q1 2023 May 12, 2023	SELL	$1.37 - $2.54 $26,412 - $48,968	-19,279 Reduced 24.65%	58,918 $149,000
Q4 2022 Feb 10, 2023	BUY	$1.67 - $2.51 $27,038 - $40,639	16,191 Added 26.11%	78,197 $146,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $9,359 - $13,990	-4,775 Reduced 7.15%	62,006 $159,000
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.09 $132,497 - $236,656	-76,588 Reduced 53.42%	66,781 $128,000
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $80,112 - $129,977	27,249 Added 23.47%	143,369 $426,000
Q4 2021 Feb 08, 2022	SELL	$4.07 - $5.3 $157,118 - $204,601	-38,604 Reduced 24.95%	116,120 $522,000
Q3 2021 Nov 15, 2021	BUY	$4.7 - $7.24 $44,410 - $68,410	9,449 Added 6.5%	154,724 $751,000
Q2 2021 Sep 13, 2021	BUY	$6.81 - $10.93 $989,322 - $1.59 Million	145,275 New	145,275 $991,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.